E-LIB Suche - Ergebnisse für: Jarlier, M

1

Évaluation sensorielle de produits innovants hyperprotidiqu..:

Guerdoux, E. ; Coutant, L. ; Renard, P....
Nutrition Clinique et Métabolisme. 37 (2023) 2 - p. e36-e37 , 2023

Link: https://doi.org/10.1016/..

2

Combined robotic approach and enhanced recovery after surge..:

Rouanet, P ; Mermoud, A ; Jarlier, M...
BJS Open. 4 (2020) 3 - p. 516-523 , 2020

Link: https://doi.org/10.1002/..

3

Évaluation de la prise en charge des effets secondaires lié..:

Kerr, C. ; Huteau, M.E. ; Jarlier, M....
Cancer/Radiothérapie. 22 (2018) 6-7 - p. 723 , 2018

Link: https://doi.org/10.1016/..

4

FOXO3a and the MAPK p38 are activated by cetuximab to induc..:

Marzi, L ; Combes, E ; Vié, N...
British Journal of Cancer. 115 (2016) 10 - p. 1223-1233 , 2016

Link: https://doi.org/10.1038/..

5

Signature moléculaire de résistance des cancers du sein RE+..:

Gamba, L. ; Vilquin, P. ; Jarlier, M...
Annales d'Endocrinologie. 75 (2014) 5-6 - p. 304 , 2014

Link: https://doi.org/10.1016/..

6

Combined robotic approach and enhanced recovery after surge..:

Rouanet, P ; Mermoud, A ; Jarlier, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260409/. , 2020

Link: http://www.ncbi.nlm.nih...

7

FOXO3a and the MAPK p38 are activated by cetuximab to induc..:

Marzi, L ; Combes, E ; Vie, N...
info:eu-repo/semantics/altIdentifier/doi/10.1038/bjc.2016.313. , 2016

Link: https://hal.umontpellier..

8

FOXO3a and the MAPK p38 are activated by cetuximab to induc..:

Marzi, L ; Combes, E ; Vié, N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104890/. , 2016

Link: http://www.ncbi.nlm.nih...

9

FOXO3a and the MAPK p38 are activated by cetuximab to induc..:

Marzi, L ; Combes, E ; Vie, N...
info:eu-repo/semantics/altIdentifier/doi/10.1038/bjc.2016.313. , 2016

Link: https://hal.umontpellier..

10

Combined robotic approach and enhanced recovery after surge..:

P. Rouanet ; A. Mermoud ; M. Jarlier...
https://doi.org/10.1002/bjs5.50281. , 2020

Link: https://doi.org/10.1002/..

11

Telacebec (Q203)-containing intermittent oral regimens ster..:

Chauffour, Aurélie ; Robert, Jérôme ; Veziris, Nicolas...
PLOS Neglected Tropical Diseases. 14 (2020) 8 - p. e0007857 , 2020

Link: https://doi.org/10.1371/..

12

Interpreting carbapenem susceptibility testing results for ..:

Micaëlo, M. ; Brossier, F. ; Bréchot, N....
Médecine et Maladies Infectieuses. 48 (2018) 5 - p. 365-371 , 2018

Link: https://doi.org/10.1016/..

13

Estimating the morbidity and mortality associated with infe..:

Colomb-Cotinat, M. ; Lacoste, J. ; Brun-Buisson, C....
Antimicrobial Resistance & Infection Control. 5 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

14

Evaluation of excreta management in a large French multi-ho..:

Lepainteur, M. ; Nérome, S. ; Bendjelloul, G....
Journal of Hospital Infection. 91 (2015) 4 - p. 346-350 , 2015

Link: https://doi.org/10.1016/..

15

Robotic Versus Laparoscopic Total Mesorectal Excision (TME)..:

Colombo, Pierre-Emmanuel ; Bertrand, Martin M. ; Alline, Mathias...
Annals of Surgical Oncology. 23 (2015) 5 - p. 1594-1600 , 2015

Link: https://doi.org/10.1245/..